Mirae Asset Healthcare Fund -Regular Growth

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 20-07-2018
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.48% As on (31-01-2020)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 402.95 Cr As on (29-02-2020)
Turn over: 30% | Exit Load: 1% for redemption within 365 days

11.72

9.05%

PERFORMANCE

Returns Type:
of  
Start :  
End : 
Period:  
This Scheme
-
vs
S&P BSE Healthcare TRI
-
Gold
-
PPF
-
Returns Type:
of  
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
There is no value for 2x
There is no value for 4x
There is no value for 5x
There is no value for 10x
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.

Current Asset Allocation (%)

Indicators

Volatility
Sharp Ratio
Alpha
Beta
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date
1 Year
Return(%)
2 Year
Return(%)
3 Year
Return(%)
5 Year
Return(%)
10 Year
Return(%)
Mirae Asset Healthcare Fund -Regular Growth 20-07-2018 10.37 - - - -
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 12.15 - - - -
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 11.12 - - - -
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 9.81 7.63 2.97 - -
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 5.7 - - - -
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 4.93 7.48 5.56 1.9 12.44
UTI Healthcare Fund - Regular Plan - Growth Option 01-08-2005 3.38 2.75 -0.12 -3.45 9.87
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 14-07-1999 3.15 1.82 -3.08 -3.96 12.49
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 - - - - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

10.75%

Others

1.37%

Large Cap

57.07%

Mid Cap

30.78%

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback